NGS panels demonstrate value in brain tumor studies
Read how the NextSeq 550 System and the TruSight Tumor 170 assay allow researchers in South Korea to identify diffuse glioma genetic markers for tumor characterization studies.
Fuel your lab
Combine proven NGS technology with tunable output to enable sequencing and array capabilities across a range of applications
Your email address is never shared with third parties.
Learn how the NextSeq 550 System is enhancing research in reproductive and genetic health and why it’s being rapidly adopted in small and large genetic testing labs. Get a glimpse into the advantages of this integrated, cost-effective solution for diverse applications.
Harness the complementary powers of sequencing and genotyping on a single instrument. Facilitate discoveries in small and large labs with:
Support evolving needs with a robust, efficient, and rapid workflow that enables tunable output:
Access fast and accurate data analysis pipelines through Illumina DRAGEN secondary analysis on BaseSpace Sequence Hub. Cloud-based, local, or on-premises server options deliver secure and user-friendly genomic insights to fuel your research.
Easily transition between high-throughput sequencing and array scanning, powered by bead-based BeadArray technology and proven Infinium chemistry. By integrating two technologies into a single instrument, the NextSeq 550 System saves instrument costs and limited lab space while maximizing available applications.
System Specifications
Prepare libraries for a range of applications with a large menu of Illumina library prep options.
Generate data in less than one day with automated sequencing.
Leverage DRAGEN secondary analysis via an on-premises server or on BaseSpace Sequence Hub for applications such as exome and transcriptome sequencing.
Share data instantly on BaseSpace Sequence Hub and enable secure, expandable storage.
From gene expression profiling to small whole-genome sequencing, the NextSeq 550 System provides reliable, accessible insights with integrated sequencing and array scanning capabilities.
Read how the NextSeq 550 System and the TruSight Tumor 170 assay allow researchers in South Korea to identify diffuse glioma genetic markers for tumor characterization studies.
Learn how researchers at the Garvan Institute of Medical Research in Sydney gain insights into 150 different proteins on the surface of thousands of single cells for investigating cancer microenvironments.
NextSeq 550 System |
|
||
Maximum output per runa | 120 Gb | 121 Gb | 360 Gb |
Maximum reads per run | 400 million | 400 million | 1.2 billiona |
Maximum read length | 2 x 150 bp | 2 x 150 bp | 2 x 150 bp |
Informatics options | On-Premises Server Cloud via BSSH |
On-Premises Server Cloud via BSSH |
On-Premises Server Cloud |
a. Based on Illumina PhiX control library at supported cluster densities.
b. For In Vitro Diagnostic Use. Not available in all regions and countries.
Contact us for more information and learn if the NextSeq 550 System is right for your lab.
Your email address is never shared with third parties.